SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Free Report) saw unusually large options trading activity on Monday. Traders acquired 129,202 put options on the company. This represents an increase of approximately 39% compared to the average volume of 92,783 put options.
SPDR S&P Biotech ETF Price Performance
XBI opened at $86.34 on Tuesday. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The company has a market capitalization of $6.62 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. The firm’s fifty day moving average price is $93.95 and its two-hundred day moving average price is $84.04.
Institutional Investors Weigh In On SPDR S&P Biotech ETF
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. ICA Group Wealth Management LLC purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter worth about $27,000. Resources Management Corp CT ADV increased its stake in shares of SPDR S&P Biotech ETF by 1,715.8% during the 2nd quarter. Resources Management Corp CT ADV now owns 345 shares of the exchange traded fund’s stock worth $29,000 after purchasing an additional 326 shares during the last quarter. Scarborough Advisors LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth approximately $32,000. Tyler Stone Wealth Management purchased a new position in SPDR S&P Biotech ETF in the second quarter valued at approximately $33,000. Finally, Compass Wealth Management LLC purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter worth $34,000.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- How to Invest in the FAANG Stocks
- The Charles Schwab Company Can Hit New Highs
- The “How” and “Why” of Investing in 5G Stocks
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.